BPC 157 Prevents and Reverses Pulmonary Hypertension in Rat Model
Background
Pulmonary hypertension (PH) is a severe and progressive condition characterized by abnormally high blood pressure in the arteries leading to the lungs, often leading to right heart failure and death. Current treatments primarily manage symptoms and slow progression, but rarely offer a cure or reversal of established disease. This study investigated the therapeutic potential of the stable gastric pentadecapeptide BPC 157 to both prevent and reverse monocrotaline-induced pulmonary hypertension in rats.
Results
BPC 157 demonstrated significant protective and therapeutic effects against monocrotaline-induced pulmonary hypertension. In the prevention study, BPC 157 at 10 µg/kg significantly attenuated the increase in right ventricular hypertrophy (RVH), reducing the RVH index by 50% compared to MCT controls (p<0.01). > The most striking finding was that BPC 157 at 10 µg/kg completely normalized pulmonary arterial pressure (PAP) in the prevention group, showing no significant difference from healthy controls (p<0.001 vs MCT-treated rats). In the reversal study, BPC 157 at 10 µg/kg significantly reduced established RVH by 35% and improved pulmonary vascular remodeling, which involves structural changes in lung blood vessels. Both doses of BPC 157 also reduced inflammatory cell infiltration and improved markers of endothelial function (the health of the inner lining of blood vessels).
Why It Matters
This study provides compelling evidence that BPC 157 could be a novel and potent therapeutic agent for pulmonary hypertension, offering both preventive and reversal capabilities. The ability to not only prevent the onset but also reverse established disease progression is particularly significant, as current therapies for PH often only slow its advancement. These findings strongly suggest BPC 157 warrants further investigation, potentially paving the way for human clinical trials for pulmonary hypertension. Future research should focus on elucidating the precise molecular mechanisms of action and confirming efficacy in larger animal models.